It seems that Flock has also joined the narrative camp of Wall Street’s DAT (Digital Asset Treasury).

Interestingly, the collaboration between FLock and CIMG Inc. is quite different from the common practice of buying ETH or BTC as reserve assets to boost stock prices. Let’s delve into the details: Specifically, FLock and CIMG Inc. have adopted a deeply integrated business collaboration model. CIMG needs to purchase FLOCK tokens as reserve assets, and the two parties will jointly develop an AI health monitoring and intelligent recommendation product called LifeNode. FLock will provide AI privacy computing and federated learning technical services for this product.

1. The currently popular DATs model on Wall Street is essentially a replica of the Crypto (3.3) model: buy coins → stock price rises → issue bonds → buy more coins. The operation of this positive flywheel relies on a one-sided market uptrend, which somewhat resembles a "Ponzi" scheme. This belongs to the first wave of speculative DATs, where Wall Street-listed companies use Crypto to hype their stock prices, and the Crypto market leverages Wall Street’s FOMO to attract external incremental funds for price pumping.

In contrast, the collaboration model between FLock and CIMG adopts a deep integration of "business + tokens." On one hand, since tokens need to be acquired, the value of FLock’s tokens becomes substantively linked to the main business of the listed company. On the other hand, FLock’s provision of AI technology services directly impacts CIMG’s strategy and market performance. In other words, their collaboration is not merely speculative炒作 but generates business synergy and value correlation.

2. To understand this deeply, we need to look into CIMG Inc. This company is quite interesting. On the surface, it started as a coffee business, but through a series of acquisitions (such as Xilin Online’s AI intelligent product selection and Huomao Culture’s "Industry + AI + Capital" four-wheel drive), it has transformed itself into a digital health group with dual engines of "technology + marketing."

This collaboration with FLock is equivalent to jumping from AI applications in marketing to AI innovation in products—with the launch of LifeNode, CIMG truly evolves from a "company that uses AI" to a "company that creates AI products." The key point is that FLock’s federated learning and privacy computing technologies恰好 address the core pain point of health data applications: How to achieve AI personalized services while protecting user privacy?

3. In fact, if the collaboration model between FLock and CIMG proves successful, it may usher in the era of DATs 2.0—productive DATs. This is because this model benefits both parties: For FLock, it gains stable B2B clients and financial support, allowing it to focus on technological R&D. For CIMG, it not only acquires advanced AI technological capabilities but also gains exposure to the growth红利 of the Crypto industry through token reserves. The key is that the implementation of LifeNode will serve as the foundation of their collaboration, and its subsequent user growth, technological iterations, and commercialization progress will all contribute to the collaborative benefits.